John Y. Kao

John Y. Kao

Gastroenterology

1500 E Medical Center Dr
Floor 3 Reception D
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Increases in Probiotic Supplement Use Exceed Microbiome-Focused Dietary Changes in US Adults and Children.

Increases in Probiotic Supplement Use Exceed Microbiome-Focused Dietary Changes in US Adults and Children.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 29, 2026

Optimising mono-antibiotic eradication regimen by potent acid inhibitor and bismuth: a potential solution to rising clarithromycin resistance in Helicobacter pylori.

Optimising mono-antibiotic eradication regimen by potent acid inhibitor and bismuth: a potential solution to rising clarithromycin resistance in Helicobacter pylori.

Journal: Gut

Published: February 16, 2026

Bismuth-Amoxicillin-Vonoprazan Triple, Amoxicillin-Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial.

Bismuth-Amoxicillin-Vonoprazan Triple, Amoxicillin-Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial.

Journal: Helicobacter

Published: February 02, 2026

Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.

Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: November 09, 2024

IL-15 Promotes Inflammatory Th17 Cells in the Intestine.

IL-15 Promotes Inflammatory Th17 Cells in the Intestine.

Journal: Inflammatory bowel diseases

Published: October 31, 2024

Association of myeloid cell reactivity patterns with safe food predictions in FPIES patients.

Association of myeloid cell reactivity patterns with safe food predictions in FPIES patients.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: September 28, 2024

Initial Diagnostic Strategies for Helicobacter Pylori in Patients With Bleeding Peptic Ulcers Undergoing Endoscopy: A Cost-Effectiveness Analysis.

Initial Diagnostic Strategies for Helicobacter Pylori in Patients With Bleeding Peptic Ulcers Undergoing Endoscopy: A Cost-Effectiveness Analysis.

Journal: Gastro hep advances

Published: July 26, 2024

Inflammation-Induced Th17 Cells Synergize with the Inflammation-Trained Microbiota to Mediate Host Resiliency Against Intestinal Injury.

Inflammation-Induced Th17 Cells Synergize with the Inflammation-Trained Microbiota to Mediate Host Resiliency Against Intestinal Injury.

Journal: Inflammatory bowel diseases

Published: June 06, 2024

A step closer to understanding how a diet high in simple carbohydrates may cause dysbiosis.

A step closer to understanding how a diet high in simple carbohydrates may cause dysbiosis.

Journal: The Journal of clinical investigation

Published: May 01, 2024

Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.

Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.

Journal: The American journal of gastroenterology

Published: October 16, 2022

Endoplasmic reticulum stress in the intestinal epithelium initiates purine metabolite synthesis and promotes Th17 cell differentiation in the gut.

Endoplasmic reticulum stress in the intestinal epithelium initiates purine metabolite synthesis and promotes Th17 cell differentiation in the gut.

Journal: Immunity

Published: September 14, 2022

Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity.

Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity.

Journal: Chinese medical journal

Published: September 07, 2022

Showing 1-12 of 92

Last Updated: 09/26/2026